Clear Harbor Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Clear Harbor Asset Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-830	Closed	-$4.49K	–	770
2020 Q3	$4.49K	Buy	+830	New	+$4.11K	﹤0.01%	680
2020 Q1	–	Sell	-350	Closed	-$1.41K	–	741
2019 Q4	$1.41K	Buy	+350	New	+$1.21K	﹤0.01%	742
2018 Q3	–	Sell	-15,119	Closed	-$154K	–	284
2018 Q2	$154K	Buy	+15,119	New	+$171K	0.03%	227

Other funds holding PRTK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clear Harbor Asset Management's PRTK Position: Q4 2020 in Review

Clear Harbor Asset Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2020, closing a stake of 830 shares — an estimated $4.49K sold.

Clear Harbor Asset Management first reported a position in PRTK in Q2 2018 and held it in 3 quarters. The position peaked at $154K in Q2 2018. 108 funds tracked by Wall St. Rank hold PRTK as of Q4 2020.

Clear Harbor Asset Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Clear Harbor Asset Management sold 830 Paratek Pharmaceuticals, Inc. shares in Q4 2020, an estimated $4.49K.
Clear Harbor Asset Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
Clear Harbor Asset Management's Paratek Pharmaceuticals, Inc. position peaked at $154K in Q2 2018.
108 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2020.

Based on Clear Harbor Asset Management's 13F filing for Q4 2020, filed 4 Feb 2021.